Skip to Content
Merck
  • Angiotensin-converting enzyme 2: central regulator for cardiovascular function.

Angiotensin-converting enzyme 2: central regulator for cardiovascular function.

Current hypertension reports (2010-04-29)
Huijing Xia, Eric Lazartigues
ABSTRACT

Angiotensin-converting enzyme 2 (ACE2) is a new component of the renin-angiotensin system (RAS). Accumulating evidence shows that ACE2 provides protective effects in peripheral tissues and has great potential for the treatment of RAS-related diseases. The role of ACE2 in the central nervous system is not well established. However, in recent years, much more progress has been made on the studies of this carboxypeptidase in the central regulation of blood pressure and cardiovascular function in general. It has been shown that brain ACE2 interacts with the other components of the RAS (ACE, angiotensin II, and angiotensin II type 1 receptor), protects baroreflex and autonomic function, stimulates nitric oxide release, reduces oxidative stress, and prevents the development of or attenuates hypertension. These data support the critical role of ACE2 in the central regulation of cardiovascular function. This review summarizes recently published data on the central effects of ACE2 in the regulation of cardiovascular function.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Angiotensin Converting Enzyme-2, ACE2, Human recombinant, ≥1000000 U/mg, expressed in HEK 293 cells